APOE and Mental deterioration: Biomarker studies in subjects with subjective cognitive decline and early mild cognitive impairment (MCI) have revealed increased Aβ deposition and decreased CSF Aβ levels in ApoE4 carriers (Risacher et al., 2013, 2015).